Yale Cancer Center

Covid-19 Blood Clotting Cause Identified in Study

29-Jun-2020 1:15 PM EDT, by Yale Cancer Center contact patient services

Newswise — One of the major mysteries in treating patients with Covid-19 is the frequent development of blood clots that can subsequently damage their organs and sometimes be fatal. New findings led by Yale Cancer Center (YCC) researchers and experts across several medical specialties at Yale identify a leading mechanism behind the pathophysiology of Covid-19 and pinpoint a biological marker for the mechanism that may aid in treating these patients. The study was published today in The Lancet Haematology.

“While many forms of illness can generate blood clots, the endothelial cells that line the inside of blood vessels play a surprisingly large role in Covid-19 clotting,” said Alfred Lee, M.D., Ph.D., Associate Professor of Medicine (Hematology) at YCC and co-senior author on the paper. “Endothelial damage is a central component in the entire spectrum of Covid-19 disease. Our study is the first to demonstrate that this process of endothelial damage is present in a wide range of Covid-19 patients, particularly as people become critically ill.”

The clinical study examined the blood of 68 patients with Covid-19, 48 of them critically ill in an intensive care unit (ICU) and 20 receiving care on a non-ICU hospital unit, along with 13 disease-free volunteers who acted as a control arm. Several markers of endothelial cell and blood platelet activation were about twice as high in the ICU group than in the non-ICU group, and also higher in the non-ICU group than in the control group.

One of the biomarkers, a soluble form of a protein on the surface of endothelial cells called thrombomodulin, was highly correlated with survival among all Covid-19 patients. This finding suggests that measuring thrombomodulin levels might aid in managing patients. “If we have a marker to identify which patients are most likely to progress towards critical illness and possibly death, that would be hugely helpful, as these patients might benefit from closer monitoring and possibly earlier intervention,” said Lee.

Hyung Chun, M.D., FAHA, Associate Professor of Medicine (Cardiology) and Pathology at Yale School of Medicine, Director of Translational Research in the Yale Pulmonary Vascular Disease Program and co-senior author on the paper, is now exploring opportunities to develop a diagnostic test based on thrombomodulin, which is also elevated in other life-threatening diseases.

“The other goal we’re pursuing in parallel is to find therapeutic strategies that could safeguard the endothelial layer and may prevent the blood clots from forming,” said Chun, whose lab studies endothelial cells. “Are there approved drugs we could potentially repurpose for this context, or could we think about other mechanisms to come up with novel therapies to ultimately protect endothelial cells?”

One early candidate among approved therapies is an oral drug called dipyridamole, long used to prevent stroke and for other conditions. The research began with a Yale Covid-19 initiative that brought together medical experts charged with making recommendations on standard treatments for the Yale New Haven Health System.

Clinical fellows George Goshua, M.D., and Alexander Pine, M.D., Ph.D., both in the hematology/oncology fellowship training program at Yale Cancer Center, and M.D./Ph.D. student Matthew Meizlish are co-first authors on the paper. Altogether, 23 Yale physicians and researchers contributed to the work. “As terrible as it is, Covid-19 brought people together who almost never would have the chance to intersect, so that we could all exchange amazing ideas and learn from each other and accomplish great science,” Lee added.

The study was supported by a gift from Jack Levin to Yale’s Benign Hematology program and by the National Institutes of Health.

About Yale Cancer Center and Smilow Cancer Hospital

Yale Cancer Center (YCC) is one of only 51 National Cancer Institute (NCI)-designated comprehensive cancer centers in the nation and the only such center in Connecticut. Cancer treatment for patients is available at Smilow Cancer Hospital through 13 multidisciplinary teams and at 15 Smilow Cancer Hospital Care Centers in Connecticut and Rhode Island. Smilow Cancer Hospital is accredited by the Commission on Cancer, a Quality program of the American College of Surgeons. Comprehensive cancer centers play a vital role in the advancement of the NCI’s goal of reducing morbidity and mortality from cancer through scientific research, cancer prevention, and innovative cancer treatment.

 

                                                                                                   #  #  #

 




Filters close

Showing results

1120 of 2836
Released: 6-Aug-2020 3:10 PM EDT
AANA Supports Improvements to Rural Health Access
American Association of Nurse Anesthetists (AANA)

To provide high-quality, value-based healthcare for millions of patients living in the nation’s rural communities, the White House issued an executive order on Aug. 3 that calls on the Department of Health and Human Services (HHS) to report on ways to eliminate regulatory burdens. The American Association of Nurse Anesthetists (AANA) is encouraged by the order which, if considered, could increase access to quality care for patients by removing costly supervision requirements of nurse anesthetists.

Released: 6-Aug-2020 12:50 PM EDT
COVID-19 Disrupts Important Research Projects, Shutters Labs Indefinitely
American Physiological Society (APS)

The coronavirus has halted critical physiological research and shuttered labs across the nation.

Released: 6-Aug-2020 12:45 PM EDT
Outside Looking In: Study Shows Variation in Hospital Visitor & ICU Communication Policies Due to COVID-19
Michigan Medicine - University of Michigan

A new study documents how 49 hospitals in a state hit hard by COVID-19 changed their visitor policies and communications with families of intensive care unit patients in the first months of the pandemic -- and how those efforts varied. Virtually all hospitals put in place a “no visitors” blanket policy, but 59% of them did allow some exceptions to this rule.

Released: 6-Aug-2020 12:40 PM EDT
Credible assumptions replace missing data in COVID analysis
Cornell University

How contagious is COVID-19, and how severe is the virus for those who’ve caught it?

Newswise: coronavirus-image1-300x300.jpg
Released: 6-Aug-2020 11:20 AM EDT
WashU Expert: Pandemic lessons from 2-1-1
Washington University in St. Louis

There have been more than 3.5 million requests for assistance to 2-1-1 help lines around the United States since the coronavirus pandemic hit this spring. The impact was immediate and dramatic, said a Brown School researcher who tracks calls to 2-1-1 help lines across the U.S.During COVID-19, the volume of requests to 2-1-1s has increased exponentially, said Matthew Kreuter, the Kahn Family Professor of Public Health at Washington University in St.

Newswise: Cancer vs. COVID: When a pandemic upended cancer care
5-Aug-2020 12:40 PM EDT
Cancer vs. COVID: When a pandemic upended cancer care
Michigan Medicine - University of Michigan

A team of researchers interviewed physicians and patients at the beginning of the COVID-19 pandemic to identify eight scenarios impacting cancer care. Using communication strategies, they created examples of language to help oncologists respond to patients empathetically.

Newswise:Video Embedded delay-in-breast-cancer-operations-due-to-covid-19-pandemic-appears-to-be-non-life-threatening-for-women-with-early-stage-disease
VIDEO
5-Aug-2020 4:25 PM EDT
Delay in breast cancer operations due to COVID-19 pandemic appears to be non-life-threatening for women with early-stage disease
American College of Surgeons (ACS)

A new breast cancer study brings reassuring findings for women with early-stage breast cancer who were forced to delay their cancer operations because of the Coronavirus Disease 2019 (COVID-19) pandemic.

Released: 6-Aug-2020 9:00 AM EDT
Blood Test May Point to Patients at Higher Risk for COVID-19 Deterioration, Death
George Washington University

George Washington University researchers found five biomarkers associated with higher odds of clinical deterioration and death in COVID-19 patients. Published in Future Medicine, these findings will help physicians better predict outcomes for COVID-19 patients in the U.S.

Released: 6-Aug-2020 8:10 AM EDT
Recovery After Severe COVID Infection Poses Unique Challenges
Michigan Medicine - University of Michigan

As more patients recovered from COVID-19 are discharged from stressed ICUs, they face multiple problems brought on by the pandemic.


Showing results

1120 of 2836

close
1.24641